Letting sleeping dos lie: Does dormancy play a role in tuberculosis?

Annual Review of Microbiology

Volumn 64, Issue , 2010, Pages 293-311

  Chao, Michael C ^a,b   Rubin, Eric J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

latency; persistence; resuscitation

Indexed keywords

ISONIAZID; NITRIC OXIDE; PYRAZINAMIDE; RNA POLYMERASE;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; BACTERIAL COUNT; BACTERIAL STRAIN; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL DIVISION; DORMANCY; ELECTRON MICROSCOPY; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; GRANULOMA; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; HUMANS; LATENT TUBERCULOSIS; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 77957946456     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.112408.134043     Document Type: Review

References (119)

1. Anuchin AM, Mulyukin AL, Suzina NES, Duda VI, El-Registan GI, Kaprelyants AS. 2009. Dormant forms of Mycobacterium smegmatis with distinct morphology. Microbiology 155:1071-79
2. Arcus VL, Rainey PB, Turner SJ. 2005. The PIN-domain toxin-antitoxin array in mycobacteria. Trends Microbiol. 13:360-65
3. Barry CE 3rd, Boshoff HJ, Dartois V, Dick T, Ehrt S, et al. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7:845-55
4. Bartek I, Rutherford R, Gruppo V, Morton R, Morris R, et al. 2009. The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb.) 89:310-16
5. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-31
6. Blumberg H, Leonard M Jr, Jasmer R. 2005. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA 293:2776-84
7. Boon C, Dick T. 2002. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J. Bacteriol. 184:6760-67
8. Bryk R, Gold B, Venugopal A, Singh J, Samy R, et al. 2008. Selective killing of nonreplicating mycobac-teria. Cell Host Microbe 3:137-45
9. Capuano SV III, Croix DA, Pawar S, Zinovik A, Myers A, et al. 2003. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71:5831-44
10. Caruso A, Serbina N, Klein E, Triebold K, Bloom B, Flynn J. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162:5407-16
11. Chan J, Tanaka K, Carroll D, Flynn J, Bloom B. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-40
12. Christensen S, Gerdes K. 2003. RelE toxins from Bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol. Microbiol. 48:1389-400
13. Cohen-Gonsaud M, Barthe P, Bagneris C, Henderson B, Ward J, et al. 2005. The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes. Nat. Struct. Mol. Biol. 12:270-73
14. Daley C, Small P, Schecter G, Schoolnik G, McAdam R, et al. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment- length polymorphisms. N. Engl. J. Med. 326:231-35
15. Daniel J, Deb C, Dubey VS, Sirakova TD, Abomoelak B, et al. 2004. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J. Bacteriol. 186:5017-30
16. Davies A, Dhillon A, Young M, Henderson B, McHugh T, Gillespie S. 2008. Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue. Tuberculosis (Edinb) 88:462-68
17. de Wit D, Wootton M, Dhillon J, Mitchison D. 1995. The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tuberc. Lung Dis. 76:555-62
18. Deb C, Lee C-M, Dubey VS, Daniel J, Abomoelak B, et al. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS ONE 4:e6077
19. DesJardin LE, Hayes LG, Sohaskey CD, Wayne LG, Eisenach KD. 2001. Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis. J. Bacteriol. 183:5311-16
20. Domenech P, Reed M. 2009. Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies. Microbiology 155:3532-43
21. Downing KJ, Mischenko VV, Shleeva MO, Young DI, Young M, et al. 2005. Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro. Infect. Immun. 73:3038-43
22. Drumm JE, Mi K, Bilder P, Sun M, Lim J, et al. 2009. Mycobacterium tuberculosis universal stress protein Rv2623 regulates bacillar growth by ATP-binding: requirement for establishing chronic persistent infection. PLoS Pathog. 5:e1000460
23. Dye C, Scheele S, Dolin P, Pathania V, Raviglione RC. 1999. Consensus statement. Global burden of tuberculosis\-estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 82:677-86
24. East African and British Medical Research Councils. 1978. Controlled clinical trial of five short-course (4-month) chemotherapy regiments in pulmonary tuberculosis: first report of fourth study. Lancet 312:334-38
25. Ehlers S. 2009. Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the Mycobacterium responsible for latent tuberculosis. Infection 37:87-95
26. Fisher MA, Plikaytis BB, Shinnick TM. 2002. Microarray analysis of the Mycobacterium tuberculosis tran-scriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 184:4025-32
27. Flesch I, Kaufmann S. 1987. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:4408-13
28. Flynn J, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129
29. Flynn J, Chan J, Triebold K, Dalton D, Steward T, Bloom B. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2248-54
30. Flynn J, Goldstein M, Triebold K, Koller B, Bloom B. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-17
31. Fox W, Ellard GA, Mitchison DA. 1999. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. Int. J. Tuberc. Lung D 3:S231-64
32. Garton NJ, Waddel SJ, Sherratt AL, Lee S-M, Smith RJ, et al. 2008. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5:0634-45
33. Ghosh J, Larsson P, Singh B, Pettersson BF, Islam NM, et al. 2009. Sporulation in mycobacteria. Proc. Natl. Acad. Sci. USA 106:10781-86
34. Giebel J, Carr K, Anderson E, Hanna P. 2009. The germination-specific lytic enzymes SleB, CwlJ1, and CwlJ2 each contribute to Bacillus anthracis spore germination and virulence. J. Bacteriol. 191:5569-76
35. Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, Sherman DR. 2009. A replication clock for Mycobacterium tuberculosis. Nat. Med. 15:211-14
36. Gupta A. 2009. Killing activity and rescue functions ofgenome-wide toxin-antitoxin loci of Mycobacterium tuberculosis. FEMS Microbiol. Lett. 290:45-53
37. Haiser HJ, Yousef MR, Elliot MA. 2009. Cell wall hydrolases affect germination, vegetative growth, and sporulation in Streptomyces coelicolor. J. Bacteriol. 191:6501-12
38. Hayes F. 2003. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301:1496-99
39. Heffron JD, Lambert EA, Sherry N, Popham DL. 2009. Contributions of four cortex lytic enzymes to germination of Bacillus anthracis spores. J. Bacteriol. 192(3):763-70
40. Hett EC, Chao MC, Deng LL, Rubin EJ. 2008. A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog. 4:e1000001
41. Hett EC, Chao MC, Steyn AJ, Fortune SM, Deng LL, Rubin EJ. 2007. A partner for the resuscitation-promoting factors of Mycobacterium tuberculosis. Mol. Microbiol. 66:658-68
42. Hirsch CS, Ellner JJ, Russell DG, Rich EA. 1994. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743-53
43. Jones G, Dyson P. 2006. Evolution of transmembrane protein kinases implicated in coordinating remodeling of gram-positive peptidoglycan: inside versus outside. J. Bacteriol. 188:7470-76
44. Kana B, Gordhan B, Downing K, Sung N, Vostroktunova G, et al. 2008. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 67:672-84
45. Kana BD, Mizrahi V. 2009. Resuscitation-promoting factors as lytic enzymes for bacteria growth and signaling. FEMS Immunol. Med. Microbiol. 11:1-11
46. Kang C-M, Abbott DW, Park ST, Dascher CC, Cantley LC, Husson RN. 2005. The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape. Gene. Dev. 19:1692-704
47. Kaprelyants AS, Kell DB. 1993. Dormancy in stationary-phase cultures of Micrococcus luteus: flow cyto-metric analysis of starvation and resuscitation. Appl. Environ. Microbiol. 59:3187-96
48. Kashino SS, Napolitano DR, Skobe Z, Campos-Neto A. 2008. Guinea pig model of Mycobacterium tuberculosis latent/dormant infection. Microbes Infect. 10:1469-76
49. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-80
50. Kesavan AK, Brooks M, Tufariello J, Chan J, Manabe YC. 2009. Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model. Tuberculosis (Edinb.) 89:17-21
51. Kim S, Lee B, Shin S, Kim H, Park J. 2008. Differentially expressed genes in Mycobacterium tuberculosis H37Rv under mild acidic and hypoxic conditions. J. Med. Microbiol. 57:1473-80
52. Klinbenberg L, Sutherland L, Bishai W, Karakousis P. 2008. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J. Infect. Dis. 198:275-83
53. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810
54. Korch S, Hill T. 2006. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188:3826-36
55. Korch SB, Contreras H, Clark-Curtiss JE. 2009. Three Mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages. J. Bacteriol. 191:1618-30
56. Kumar A, Toleda JC, Patel RP, Lancaster JR Jr, Steyn AJ. 2007. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc. Natl. Acad. Sci. USA 104:11568-74
57. Lavollay M, Arthur M, Fourgeaud M, Dubost L, Marie A, et al. 2008. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation. J. Bacteriol. 190:4360-66
58. Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, Voskuil MI. 2009. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J. Bacteriol. 192(6):1662-70
59. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56
60. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VØ, Andersen OB. 2002. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 185:401-4
61. Lillebaek T, Dirksen A, Vynnycky E, Baess I, Thomsen VO, Andersen AB. 2003. Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. J. Infect. Dis. 188:1032-39
62. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, et al. 2009. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77:4631-42
63. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-73
64. Low KL, Rao PSS, Shui G, Bendt AK, Pethe K, et al. 2009. Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin. J. Bacteriol. 191:5037-43
65. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-48
66. Manabe Y, Dannenberg A Jr, Tyagi S, Hatem C, Yoder M, et al. 2003. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 71:6004-11
67. Manabe YC, Kesavan AK, Lopez-Molina J, Latern CL, Brooks M, et al. 2008. The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis (Edinb.) 88:187-96
68. McCune RM, Feldmann FM, Lambert HP, McDermott W. 1966. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123:445-68
69. McCune RM, Feldmann FM, McDermott W. 1966. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J. Exp. Med. 123:469-86
70. McCune RM Jr, Tompsett R, McDermott W. 1956. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. J. Exp. Med. 104:737-62
71. McKinney JD, Honer Zu BK, Munoz-Elias EJ, Miczak A, Chen B, et al. 2000. Persistence of Mycobac-terium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-38
72. McMurray D. 2001. Disease model: pulmonary tuberculosis. Trends Mol. Med. 7:135-37
73. Mitchison DA. 2004. The search for new sterilizing antituberculosis drugs. Front. Biosci. 9:1059-72
74. Mukamolova G, Turapov O, Malkin J, Woltmann G, Barer MR. 2010. Resuscitation promoting factors reveal an occult population of tubercle bacilli in sputum. Am. J. Respir. Crit. Care Med. 181:174-80
75. Mukamolova GV, Turapov OA, Young DI, Kaprelyants AS, Kell DB, Young M. 2002. A family of autocrine growth factors in Mycobacterium tuberculosis. Mol. Microbiol. 46:623-35
76. Munoz-Elias EJ, McKinney JD. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-44
77. Munoz-Elias EJ, Timm J, Botha T, Chan W-T, Gomez JE, McKinney JD. 2005. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73:546-51
78. Muttucumaru DG, Roberts G, Hinds J, Stabler RA, Parish T. 2004. Gene expression profile of Mycobac-terium tuberculosis in a nonreplicating state. Tuberculosis (Edinb.) 84:239-46
79. Ohno H, Zhu G, Mohan V, Chu D, Kohno S, et al. 2003. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell Microbiol. 5:637-48
80. Oliver JD. 2005. The viable but nonculturable state in bacteria. J. Microbiol. 43:93-100
81. Opie E. 1927. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch. Pathol. Lab Med. 4:1-21
82. Paramasivan C, Sulochana S, Kubendiran G, Venkatesan P, Mitchison D. 2005. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic-and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:627-31
83. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, et al. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48:833-43
84. Pedersen K, Christensen S, Gerdes K. 2002. Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45:501-10
85. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, et al. 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4:e75
86. Pierce C, Dubos R, Schaefer W. 1953. Multiplication and survival of tubercle bacilli in the organs of mice. J. Exp. Med. 97:189-206
87. Polesky A, Farber H, Gottlieb D, Park H, Levinson S, et al. 1996. Rifampin preventive therapy for tuberculosis in Boston's homeless. Am. J. Respir. Crit. Care Med. 154:1473-77
88. Ramage HR, Connolly LE, Cox JS. 2009. Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet. 5:e1000767
89. Rees R, Hart P. 1961. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br. J. Exp. Pathol. 42:83-88
90. Rifat D, Bishai WR, Karakousis PC. 2009. Phosphate depletion: a novel trigger for Mycobacterium tuberculosis persistence. J. Infect. Dis. 200:1126-35
91. Russell D. 2007. Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5:39-47
92. Russell-Goldman E, Xu J, Wang X, Chan J, Tufariello J. 2008. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 76:4269-81
93. Rustad TR, Harrell MI, Liao R, Sherman DR. 2008. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One 3:e1502
94. Rustad TR, Sherrid AM, Minch KJ, Sherman DR. 2009. Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol. 11:1151-59
95. Saunders B, Britton W. 2007. Life and death in the granuloma: immunopathology of tuberculosis. Immunol. Cell Biol. 85:103-11
96. Saunders B, Frank A, Orme I. 1999. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 98:324-28
97. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, et al. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704
98. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6:53
99. Shah IM, Laaberki M-H, Popham DL, Dworkin J. 2008. A eukaryotic-like Ser/ Thr kinase signals bacteria to exit dormancy in response to peptidoglycan fragments. Cell 135:486-96
100. Shleeva MO, Bagramyan K, Telkov MV, Mukamolova GV, Young M, et al. 2002. Formation and resuscitationof"nonculturable" cells ofRhodococcus rhodochrous and Mycobacterium tuberculosisin prolonged stationary phase. Microbiology 148:1581-91
101. Shleeva MO, Mukamolova GV, Young M, Williams HD, Kaprelyants AS. 2004. Formation of "non-culturable" cells of Mycobacterium smegmatis in stationary phase in response to growth under suboptimal conditions and their Rpf-mediated resuscitation. Microbiology 150:1687-97
102. Sirakova T, Dubey V, Deb C, Daniel J, Korotkova T, et al. 2006. Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology 152:2717-25
103. Spoering A, Lewis K. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-51
104. Talaat AM, Lyons R, Howard ST, Johnston SA. 2004. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 101:4602-7
105. Traag BA, Driks A, Stragier P, Bitter W, Broussard G, et al. 2010. Do mycobacteria produce endospores? Proc. Natl. Acad. Sci. USA. 107:878-81
106. Tsai MC, Chakraavarty S, Zhu G, Zu J, Tanaka K, et al. 2006. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol. 8:218-32
107. Tufariello JM, Mi K, Xu J, Manabe YC, Kesavan AK, et al. 2006. Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect. Immun. 74:2985-95
108. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. 2008. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76:2333-40
109. Voskuil M. 2004. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb.) 84:138-43
110. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, et al. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-13
111. Voskuil MI, Visconti KC, Schoolnik GK. 2004. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb.) 84:218-27
112. Wallis RS, Patil S, Cheon S-H, Edmonds K, Phillips M, et al. 1999. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2600-6
113. Wayne L. 1954. Growth of Mycobacterium tuberculosis from resected specimens under various atmospheric conditions. Am. Rev. Tuberc. 70:910-11
114. Wayne LG, Lin KY. 1982. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 37:1042-49
115. Wayne LG, Sohaskey CD. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-63
116. Wayne LG, Sramek HA. 1994. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:2054-58
117. Wiegeshaus E, McMurray D, Grover A, Harding G, Smith D. 1970. Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am. Rev. Respir. Dis. 102:422-29
118. Wu X, Yang Y, Han Y, Zhang Y, Liang H, et al. 2008. Effect of recombinant Rv1009 on promoting the growth of Mycobacterium tuberculosis. J. Appl. Microbiol. 105:1121-27
119. Zhang Y. 2004. Persistent and dormant tubercle bacilli and latent tuberculosis. Front. Biosci. 9:1136-56